4.7 Review

A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe

Journal

MICROBIAL CELL FACTORIES
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12934-015-0229-1

Keywords

Beneficial microbes; Probiotic; Regulation; Safety; Gastro Intestinal (GI) tract

Funding

  1. FPARIS collaborative project
  2. Vitagora Competitive Cluster
  3. French FUI (Fond Unique Interministeriel
  4. FUI) [F1010012D]
  5. FEDER (Fonds Europeen de Developpement Regional
  6. Bourgogne) [34606]
  7. Burgundy Region
  8. Conseil General 21
  9. Grand Dijon

Ask authors/readers for more resources

This paper concerns the procedure and the scientific approach to obtain market authorization for a microorganism to be recognized as a novel food with a health claim. Microorganisms that have not been traditionally used during food production in Europe prior to 1997 are considered as novel foods, which should undergo an in-depth characterization and safety assessment before being authorized on the European market. If a novel food bacterium is claimed to provide a beneficial effect on health, these claims must also be investigated before they can be authorized. Some requirements to obtain novel food certification are shared with those required to obtain a health claim. Although regulation exists that deals with these issues for foods in general, bacteria in food raise a specific set of questions that are only minimally addressed in official documentation. We propose a framework and suggest a list of criteria that should be assessed to obtain marketing authorization and health claim for a bacterium in accordance with European health policy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available